89bio, Inc. (ETNB)
2025-06-30 | ||||
|---|---|---|---|---|
| Foreign currency translation adjustments | -19 | |||
| Unrealized loss on marketable securities | -244 | |||
| Total other comprehensive loss | -263 | |||
| Income tax expense | 753 | |||
| Interest income and other, net | 6,210 | |||
| Loss from operations | -115,824 | |||
| Interest expense | 1,137 | |||
| Net loss before income tax | -110,751 | |||
| Net loss | -111,504 | |||
| Comprehensive loss | -111,767 | |||
| Earnings per share, basic, total | -0.71 | |||
| Net loss per share, diluted | -0.71 | |||
| Weighted average number of shares outstanding, basic, total | 157,880,203 | |||
| Weighted average number of shares outstanding, diluted, total | 157,880,203 | |||